Roy Proujansky
Direttore/Membro del Consiglio presso Rheonix, Inc.
Profilo
Roy Proujansky is currently the CEO-Delaware Valley Operations & Executive VP at Dupont Hospital for Children and also serves as the Director at Rheonix, Inc. He previously worked as the Chairman-Pediatrics Department & Associate Dean at Sidney Kimmel Medical College from 2000 to 2006, as the Chief Operating Officer & EVP-Patient Operations at The Nemours Foundation from 2006 to 2013, and as an Independent Director at 9 Meters Biopharma, Inc. from 2018 to 2020.
He also worked as an Assistant Professor at the University of Pittsburgh School of Medicine.
Dr. Proujansky received his undergraduate degree from Northwestern University in 1978, his doctorate from Northwestern University in 1980, and his MBA from the University of Massachusetts.
Posizioni attive di Roy Proujansky
Società | Posizione | Inizio |
---|---|---|
Dupont Hospital for Children | Corporate Officer/Principal | 01/07/2013 |
Rheonix, Inc.
Rheonix, Inc. Medical SpecialtiesHealth Technology Rheonix, Inc. operates microfluidic platform for the molecular diagnostics industry. It is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. The firm's platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD cartridge. The company was founded by Greg Galvin in 2007 and is headquartered in Ithaca, NY. | Direttore/Membro del Consiglio | 29/01/2021 |
Precedenti posizioni note di Roy Proujansky
Società | Posizione | Fine |
---|---|---|
9 METERS BIOPHARMA, INC. | Direttore/Membro del Consiglio | 30/06/2020 |
The Nemours Foundation
The Nemours Foundation Investment Trusts/Mutual FundsMiscellaneous The Nemours Foundation is a pediatric health system is engaged in activities that promote higher standards of children's health. It offers a spectrum of clinical treatment, research, advocacy, and educational health and prevention services extending to families in the communities it serves. Nemours Foundation was founded in Alfred I. duPont in 1936. Its headquarters are located in Jacksonville, FL. | Direttore operativo | 01/07/2013 |
Sidney Kimmel Medical College | Corporate Officer/Principal | 01/01/2006 |
University of Pittsburgh School of Medicine | Corporate Officer/Principal | - |
Formazione di Roy Proujansky
Northwestern University | Doctorate Degree |
University of Massachusetts | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
9 METERS BIOPHARMA, INC. | Health Technology |
Aziende private | 3 |
---|---|
Rheonix, Inc.
Rheonix, Inc. Medical SpecialtiesHealth Technology Rheonix, Inc. operates microfluidic platform for the molecular diagnostics industry. It is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. The firm's platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD cartridge. The company was founded by Greg Galvin in 2007 and is headquartered in Ithaca, NY. | Health Technology |
The Nemours Foundation
The Nemours Foundation Investment Trusts/Mutual FundsMiscellaneous The Nemours Foundation is a pediatric health system is engaged in activities that promote higher standards of children's health. It offers a spectrum of clinical treatment, research, advocacy, and educational health and prevention services extending to families in the communities it serves. Nemours Foundation was founded in Alfred I. duPont in 1936. Its headquarters are located in Jacksonville, FL. | Miscellaneous |
Dupont Hospital for Children |
- Borsa valori
- Insiders
- Roy Proujansky